ANTIDOTE TREATMENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC a delivery order under contract SPE2DX25D9900 for an antidote treatment identified by NSN 6505015997373 and PR 7017430107. The total contract value is $1,444.88, with the award officially issued on July 8, 2026. The order falls under solicitation SPE2DP26F7213 and is classified as a federal award with no set-aside designation. The item is intended for use by the Department of Defense, though specific delivery or performance locations are not provided in the data. The contract is managed through the DIBBS system, with additional details accessible via the provided uiLink.
General Info
Agency
Contract Value
$1,444.88NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
